Hu et al. used Hsp90 inhibitor SNX2112 to treat human cervical cancer cells, and caused TRAIL-induced apoptosis of human cervical cancer cells (Hu et al. 2019). This evidence concerns the gene TNFSF10 and cervical cancer.